Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).

Rojas P, Benavides F, Blando J, Perez C, Cardenas K, Richie E, Knudsen ES, Johnson DG, Senderowicz AM, Rodriguez-Puebla ML, Conti CJ.

Mol Carcinog. 2009 Jun;48(6):508-16. doi: 10.1002/mc.20489.

2.

Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.

Zeng Z, Tu J, Cheng J, Yao M, Wu Y, Huang X, Xie X, Zhang X, Lu F, Chen X.

Tumour Biol. 2015 Sep;36(9):6891-900. doi: 10.1007/s13277-015-3401-7.

3.

CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.

Chen X, Zhao T, Li L, Xu C, Zhang X, Tse V, Zhang T, Liu X, Lu F.

DNA Cell Biol. 2012 Jun;31(6):1107-13. doi: 10.1089/dna.2011.1521.

PMID:
22304571
4.

Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.

Abramson VG, Troxel AB, Feldman M, Mies C, Wang Y, Sherman L, McNally S, Diehl A, Demichele A.

Anticancer Res. 2010 Apr;30(4):1279-85.

5.

Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.

Paronetto MP, Cappellari M, Busà R, Pedrotti S, Vitali R, Comstock C, Hyslop T, Knudsen KE, Sette C.

Cancer Res. 2010 Jan 1;70(1):229-39. doi: 10.1158/0008-5472.CAN-09-2788.

6.

Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.

Kim CJ, Tambe Y, Mukaisho K, Sugihara H, Isono T, Sonoda H, Shimizu T, Kondoh G, Inoue H.

Carcinogenesis. 2014 Jan;35(1):227-36. doi: 10.1093/carcin/bgt293.

PMID:
23975835
7.

Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.

Olshavsky NA, Comstock CE, Schiewer MJ, Augello MA, Hyslop T, Sette C, Zhang J, Parysek LM, Knudsen KE.

Cancer Res. 2010 May 15;70(10):3975-84. doi: 10.1158/0008-5472.CAN-09-3468.

8.

Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.

Kim CJ, Nishi K, Isono T, Okuyama Y, Tambe Y, Okada Y, Inoue H.

Mol Carcinog. 2009 Oct;48(10):953-64. doi: 10.1002/mc.20547.

PMID:
19415719
9.

Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES.

J Biol Chem. 2003 Aug 8;278(32):30339-47. Erratum in: J Biol Chem. 2004 Jul 16;279(29):30914.

10.

Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.

Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D, Dutertre M.

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6004-9. doi: 10.1073/pnas.0710748105.

11.

Cyclin K and cyclin D1b are oncogenic in myeloma cells.

Marsaud V, Tchakarska G, Andrieux G, Liu JM, Dembele D, Jost B, Wdzieczak-Bakala J, Renoir JM, Sola B.

Mol Cancer. 2010 May 10;9:103. doi: 10.1186/1476-4598-9-103.

12.

Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.

Robles AI, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL, Conti CJ.

Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7634-8.

13.

Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.

Li R, An SJ, Chen ZH, Zhang GC, Zhu JQ, Nie Q, Xie Z, Guo AL, Mok TS, Wu YL.

Hum Pathol. 2008 Dec;39(12):1792-801. doi: 10.1016/j.humpath.2008.05.008.

PMID:
18715616
14.

An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.

Lu F, Gladden AB, Diehl JA.

Cancer Res. 2003 Nov 1;63(21):7056-61.

15.

Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.

Gupta VK, Feber A, Xi L, Pennathur A, Wu M, Luketich JD, Godfrey TE.

Clin Cancer Res. 2008 Dec 1;14(23):7804-12. doi: 10.1158/1078-0432.CCR-08-0744.

16.

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.

Millar EK, Dean JL, McNeil CM, O'Toole SA, Henshall SM, Tran T, Lin J, Quong A, Comstock CE, Witkiewicz A, Musgrove EA, Rui H, Lemarchand L, Setiawan VW, Haiman CA, Knudsen KE, Sutherland RL, Knudsen ES.

Oncogene. 2009 Apr 16;28(15):1812-20. doi: 10.1038/onc.2009.13.

17.

Consequence of the tumor-associated conversion to cyclin D1b.

Augello MA, Berman-Booty LD, Carr R 3rd, Yoshida A, Dean JL, Schiewer MJ, Feng FY, Tomlins SA, Gao E, Koch WJ, Benovic JL, Diehl JA, Knudsen KE.

EMBO Mol Med. 2015 May;7(5):628-47. doi: 10.15252/emmm.201404242.

18.

Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.

Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE.

Clin Cancer Res. 2009 Sep 1;15(17):5338-49. doi: 10.1158/1078-0432.CCR-08-2865.

19.

Identification of the cyclin D1b mRNA variant in mouse.

Wu J, Wu SH, Bollig A, Thakur A, Liao DJ.

Mol Biol Rep. 2009 May;36(5):953-7. doi: 10.1007/s11033-008-9267-7.

20.

Supplemental Content

Support Center